681 related articles for article (PubMed ID: 25552583)
21. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
22. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
23. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
[TBL] [Abstract][Full Text] [Related]
25. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
[TBL] [Abstract][Full Text] [Related]
26. The bile salt export pump.
Stieger B; Meier Y; Meier PJ
Pflugers Arch; 2007 Feb; 453(5):611-20. PubMed ID: 17051391
[TBL] [Abstract][Full Text] [Related]
27. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.
Soroka CJ; Boyer JL
Mol Aspects Med; 2014 Jun; 37():3-14. PubMed ID: 23685087
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of the canalicular bile salt export pump of human liver.
Noé J; Stieger B; Meier PJ
Gastroenterology; 2002 Nov; 123(5):1659-66. PubMed ID: 12404240
[TBL] [Abstract][Full Text] [Related]
30. Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations.
Cai SY; Wang L; Ballatori N; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G316-22. PubMed ID: 11447010
[TBL] [Abstract][Full Text] [Related]
31. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
[TBL] [Abstract][Full Text] [Related]
32. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
33. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
35. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.
Wang R; Salem M; Yousef IM; Tuchweber B; Lam P; Childs SJ; Helgason CD; Ackerley C; Phillips MJ; Ling V
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2011-6. PubMed ID: 11172067
[TBL] [Abstract][Full Text] [Related]
36. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
37. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice.
Lam P; Wang R; Ling V
Biochemistry; 2005 Sep; 44(37):12598-605. PubMed ID: 16156672
[TBL] [Abstract][Full Text] [Related]
38. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
Kosters A; Frijters RJ; Schaap FG; Vink E; Plösch T; Ottenhoff R; Jirsa M; De Cuyper IM; Kuipers F; Groen AK
J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
[TBL] [Abstract][Full Text] [Related]
39. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
40. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
